Compartilhar
Informação da revista
Vol. 95. Núm. 4.
Páginas 531-533 (1 julho 2020)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Visitas
6182
Vol. 95. Núm. 4.
Páginas 531-533 (1 julho 2020)
Research Letter
Open Access
Melanoma risk factors in a Latin American population
Visitas
6182
John Alexander Nova, Guillermo Sánchez-Vanegas, Mauricio Gamboa, Sebastian Ramiro Gil-Quiñones
Autor para correspondência
sebastian.gil@urosario.edu.co

Corresponding author.
Department of Skin Cancer Teaching and Research, Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Tabelas (3)
Table 1. Histologic melanoma subtypes in the studied cases.
Table 2. Differences between variables related to sun exposure and phenotypic features for patients with melanoma and for controls.
Table 3. Risk factors for developing melanoma according to multivariate analysis.
Mostrar maisMostrar menos
Texto Completo
Dear Editor,

Malignant melanoma (MM) is a skin tumor associated with a high mortality worldwide. The five-year survival rate is 95% if melanoma is detected early and only 5% for metastatic melanoma.1 In Colombia, the national registry reported an increased incidence of melanoma from four to six cases per 100,000 people in merely four years.2 This highlights the importance of identifying melanoma risk factors, especially in Latin-American countries were the distribution of histopathological subtypes of melanoma is divergent with the reports in other countries, where acral lentiginous melanoma (ALM) is the most frequent MM subtype.3 Although a possible association with trauma has been reported, this association has not been clearly demonstrated.4,5

Considering the aforementioned, a case-control study was performed between 2010 and 2014 in the population seen at the Federico Lleras Acosta Dermatology Center, a dermatological referral hospital in Bogotá, Colombia. Data from patients histologically diagnosed with melanoma were collected. The controls were those patients admitted to the same hospital for non-melanoma dermatological disease or non-melanoma skin cancer. All controls underwent a questionnaire and physical examination verifying that they had neither melanoma nor lesions clinically suggestive of melanoma. The cases and controls were age-matched by approximately five years. Two controls were assigned to each case

Sociodemographic variables, history of working outdoors and outdoor sports participation throughout life, insecticide exposure, smoking, sunburn history, and a family history of skin cancer were studied. Individual phenotypic features including skin phototype, eye color, hair color, and signs of sun damage were also studied.

Associations through the chi-squared test, Student's t-test and Wilcoxon rank-sum were used for statistical analyses and a multivariate analysis using conditional logistic regression was performed, with statistically significant, clinically relevant, and potentially confounding variables included. Data were analyzed using the statistical software Stata.

This study included a total of 243 participants; 81 cases and 162 controls. The average subject age was 64 years. Analyzing the age by subtype, the patients with lentigo maligna averaged 67 years; the patients with acral lentiginous melanoma and nodular melanoma averaged 63 years; and those with superficial spreading melanoma averaged 58 years.

Of the total participants, 160 were women (66%) and 83 were men (34%). In the case group, the female percentage was 68% (55/81); in the control group, it was 65% (105/162). Table 1 shows the histologic classification of the tumors. The most common melanoma subtype was acral lentiginous melanoma (32%), followed by lentigo maligna (29%). The melanomas were located mostly on the cheeks 21/81 (26%), nails 14/81 (26%), nose 11/81 (13%), and the soles of the feet 9/81 (11%).

Table 1.

Histologic melanoma subtypes in the studied cases.

Histologic subtype  Cases (n=81)
  n 
In situ melanomas
Lentigo maligna  24  29.62 
Other in situ melanomas  11.11 
Invasive melanomas
Acral lentiginous melanoma  26  32.09 
Nodular melanoma  10  12.34 
Superficial spreading melanoma  4.93 
Lentigo maligna melanoma  4.93 
Non-categorized malignant melanoma  4.93 

Nearly 73% (59/81) of the cases had completed secondary school, compared with 71% (115/162) of the controls, which was not a significant difference (p=0.7 by chi-squared test).

Table 2 shows the results of the bivariate analysis which reveals that having worked outdoors during early adult life (15–30 years old) increased the risk of developing melanoma by 1.9 times. The most frequent occupations among cases and controls in this period were farming activities (54% vs. 67%), construction (5% vs. 4%), and outdoor sales (11% vs. 14%). No significant differences were found between both groups.

Table 2.

Differences between variables related to sun exposure and phenotypic features for patients with melanoma and for controls.

Variable  CasesControlsp-Value (chi2OR  95% CI 
       
Outdoor work between 15 and 30 years of age  37/81  46  49/162  30  0.01  1.93  1.07–3.48 
Insecticide exposure  9/81  11  4/160  2.5  0.005  4.8  1.29–22.23 
Outdoor sports after 30 years of age  15/81  18  58/162  36  0.00  0.4  0.19–0.80 
More than 5 sunburns in life  18/81  22  4/162  0.00  11.28  3.49–47.13 
More than 5 sunburns in childhood (<16 years old)  10/81  12  3/162  1.85  0.00  7.46  1.83–43.08 
More than 5 sunburns between 15 and 30 years of age  18/81  22  13/162  0.001  3.27  1.41–7.70 
More than 5 sunburns after 30 years of age  10/80  12  4/162  0.00  5.64  1.55–25.30 
Personal history of skin cancer  3/80  0/162  0.03 
Light eyes (green, blue, or hazel)  67/81  83  73/162  45  0.00  5.83  2.93–12.09 
Light hair (blond, red, or brown)  47/81  58  38/162  23  0.00  4.51  2.44–8.31 
Actinic conjunctivitis  25/79  32  19/162  12  0.00  3.48  1.68–7.24 
Actinic comedones  2/79  19/162  12  0.01  0.19  0.02–0.84 
Poikiloderma of Civatte  47/79  59  41/162  25  0.00  4.33  2.35–7.99 
Numerous freckles  11/81  13  2/162  0.00  12.57  2.61–118.3 
Numerous lentigines on face  10/81  12  6/162  0.01  3.66  1.14–12.68 

The signs of chronic sun damage increased the risk of developing melanoma (Table 2). Phototypes 1 and 2 were more frequent in the case group – 51% (41/81) than in the control group – 42% (68/162); however, this difference was not significant.

History of insecticide exposure increased the risk of developing melanoma fourfold (OR=4.8, 95% CI 1.29–22.23). Acral lentiginous melanoma was exhibited in 36% (4/11) of patients who reported exposure to pesticides. No significant differences between cases and controls were found in the other studied variables, such as smoking (35/81 vs. 72/162), sunscreen use (3/80 vs. 8/162), or the use of tanning beds (0).

Table 3 shows the risk factors identified after multivariate analysis, which included having blue or green eyes, actinic conjunctivitis, numerous freckles, and a history of ten or more sunburns throughout life.

Table 3.

Risk factors for developing melanoma according to multivariate analysis.

Variable  OR  p  95% CI 
Blue or green eyes  4.62  0.00  2.24–9.52 
Actinic conjunctivitis  4.95  0.00  2.25–10.91 
Numerous freckles  11.35  0.00  2.00–64.12 
Ten or more sunburns throughout life  8.34  0.00  2.49–28.17 
LR Chi: 77.58       
Pseudo R2: 0.25       

This study found that, although skin phototypes III and IV predominate in Colombia, phenotypic characteristics such as hair color, light eyes (green, hazel, or blue), as well as the number of freckles and the history of sunburn increase the risk of developing MM.

Consistent with previous studies, this population develops ALM as the predominant MM subtype. The association found between exposure to insecticides and risk of melanoma could strengthen the argument that this is one important element in the explanation of ALM pathophysiology.

Financial support

This study was developed and funded entirely by the Federico Lleras Acosta Dermatology Center.

Authors’ contributions

John Alexander Nova: Approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Guillermo Sánchez Vanegas: Statistical analysis; approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Mauricio Gamboa: Approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Sebastian Ramiro Gil Quiñones: Approval of the final version of the manuscript; conception and planning of the study; drafting and editing of the manuscript; collection, analysis, and interpretation of data; participation in study design; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases; critical review of the literature; critical review of the manuscript.

Conflicts of interest

None declared.

References
[1]
A.V. Giblin, J.M. Thomas.
Incidence, mortality and survival in cutaneous melanoma.
J Plast Reconstr Aesthet Surg, 60 (2007), pp. 32-40
[2]
G.N.J. Sánchez, F. de la Hoz, C. Castañeda.
Incidencia de cáncer de piel en Colombia, años 2003–2007.
Piel, 26 (2011), pp. 7
[3]
F.V. Brandão, A.F. Pereira, B. Gontijo, F.V. Bittencourt.
Epidemiological aspects of melanoma at a university hospital dermatology center over a period of 20 years.
An Bras Dermatol, 88 (2013), pp. 344-353
[4]
H.J. Jung, S.S. Kweon, J.B. Lee, S.C. Lee, S.J. Yun.
A clinicopathologic analysis of 177 acral melanomas in Koreans: relevance of spreading pattern and physical stress.
JAMA Dermatol, 149 (2013), pp. 1281-1288
[5]
Y. Li, H. Chen, G. Chen, J. Liu, H. Zhu, B. Nugasur, et al.
Trauma could as a triggering factor for development of acral lentiginous melanoma: a clinicopathologic study of 56 cases.
Int J Clin Exp Pathol, 9 (2016), pp. 7800-7806

How to cite this article: Nova JA, Sánchez-Vanegas G, Gamboa M, Gil-Quiñones SR. Melanoma risk factors in a Latin American population. An Bras Dermatol. 2020;95:531–3.

Study conducted at the Centro Dermatológico Federico Lleras Acosta, Bogotá, Colombia.

Copyright © 2020. Sociedade Brasileira de Dermatologia
Baixar PDF
Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
Opções de artigo
Ferramentas
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.